Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 601–700 of 942
Huang, B., Zhang, J., Zong, W., Chen, S., Zong, Z., Zeng, X., & Zhang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.994698 · Cited by 18
“Recently, the secretion of periostin from glioma stem cells (GSCs) has also been demonstrated to support macrophage recruitment and transition into an M2 phenotype, and the deletion of POSTN in GSCs resulted in a dramatic reduction of GAM density and GBM growth, as well as an increased survival rate of mice bearing GS…”
BackgroundDomenico, P. D., Gagliardi, F., Roncelli, F., Snider, S., & Mortini, P. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-04989-z · Cited by 14
“…[118], LOX/SPP1 [119], TNFα [120], CCL5/CX3CL1 [121], CHI3L1 [122], CSF1/CSF-1R/IFN-γ [123], IDO1 [124], OLFML3/CLOCK [125] recruiting TAMs, and αvβ3 [126], CXCL8 [127], PGE2 [128], p-ERK [129], OPN [130], LGMN [131], TIM-3 [132], MARCO [133], NOTCH1 [134] promoting TAM immunotolerant phenotypes.”
Shang, Y., Liang, Y., Zhang, B., Wu, W., Peng, Y., Wang, J., Zhang, M., & Niu, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-92969-8 · Cited by 14
Esteban-Román, N. F., Taddei, E., Castro-Velázquez, E., Villafuentes-Vidal, L., Velez-Herrera, A., Rubio‐Osornio, M., & Rubio, C. (2025) · Brain Sciences · doi:10.3390/brainsci15080884 · Cited by 16
“In addition, the absence of PTEN is associated with the proliferation of GSC populations and increased resistance to radiotherapy, accentuating the clinical significance of targeting this pathway in GBM [77,78].”
Evolutionary scalpels for dissecting tumor ecosystems
Rosenbloom, D. I. S., Cámara, P. G., Chu, T., & Rabadán, R. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.11.005 · Cited by 12
“Transition from the proneural to the mesenchymal phenotype is stimulated by secretion of tumor necrosis factor-α (TNF-α) by macrophages [107], which themselves are recruited to the perivascular tumor environment by BTSCs [109].”
BackgroundReflected stemness as a potential driver of the tumour microenvironment
Rodrigues, F. S., Ciccarelli, F. D., & Malanchi, I. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.04.007 · Cited by 11
Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies
Higginbottom, S. L., Tomaskovic‐Crook, E., & Crook, J. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10100-7 · Cited by 14
Erythropoietin-Derived Peptide Protects Against Acute Lung Injury After Rat Traumatic Brain Injury
Liu, Y., Lu, J., Wang, X., Chen, L., Liu, S., Zhang, Z., & Yao, W. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475434 · Cited by 11
Mowday, A. M., Lieuwes, N. G., Biemans, R., Marcus, D., Rezaeifar, B., Reniers, B., Verhaegen, F., Theys, J., & Dubois, L. J. (2020) · Cancers · doi:10.3390/cancers12061585 · Cited by 15
“…important role in GBM progression through a variety of mechanisms, including recruitment of M2-associated macrophages to the tumor microenvironment [34] and expression of potent immunosuppressive factors including TGF-β (transforming growth factor beta) and PD-L1 (programmed death-ligand 1) [35].”
Yang, Z., Tian, X., Wang, C., Yao, K., Yang, Y., Zhang, L., Liu, N., Han, S., Qi, X., & Han, S. (2023) · Brain Sciences · doi:10.3390/brainsci13020164 · Cited by 12
“Some researchers have shown that M2 macrophages generally contribute to tumor initiation, progression, invasion, and angiogenesis and are correlated with poor prognosis of many cancers, including glioblastoma (GBM) [6,7].”
BackgroundInfluentialZinn, P. O., Hatami, M., Youssef, E., Thomas, G. A., Luedi, M. M., Singh, S. K., & Colen, R. R. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001302 · Cited by 11
Chu, T., Wang, Z., Pe’er, D., & Danko, C. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.07.897900 · Cited by 12
Li, X., Hu, J., Zheng, W., Fan, Z., Chi, H., Li, H. R., Wang, Y., & Jing, Z. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70489 · Cited by 10
“This secretion allows GSCs to recruit TAMs via integrin αvβ3 and maintain the immunosuppressive M2 phenotype of TAMs, thereby supporting GBM growth and angiogenesis [60].”
Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
Liu, E., Li, W., Jian, L.-P., Yin, S., Yang, S., Zhao, H., Huang, W., Zhang, Y., & Zhou, H. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101739 · Cited by 9
Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy
Chakraborty, S., Mukherjee, S., Basak, U., Pati, S., Dutta, A., Dutta, S., Dhar, S., Sarkar, T., Guin, A., Sa, G., et al. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00108 · Cited by 13
Ma, J., Chen, Z., Li, Q., Wang, L., Chen, J., Yang, X., Yang, C., & Quan, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-52738-5 · Cited by 12
“M2-type TAMs promote cancer stem-like properties in tumors, including hepatocellular carcinoma 62 , breast cancer 63 , non-small cell lung cancer 64 , pancreatic ductal adenocarcinoma 65 , and glioblastoma multiforme 66 .”
Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression
Ma, T., Su, G., Wu, Q., Shen, M., Feng, X., & Zhang, Z. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09196-5 · Cited by 12
“Flow cytometry studies have shown that most TAMs in gliomas are derived from monocyte-derived macrophages, not from resident microglia [33].”
Vasiļevska, J., Cheng, P. F., Lehmann, J., Ramelyte, E., Gómez, J. M. M., Dimitriou, F., Sella, F., Ferretti, D., Salas-Bastos, A., Jordaan, W., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101611 · Cited by 21
An, W., Ren, C., Yuan, L., Qiu, Z., Wang, P., Cheng, Y., He, Z., Han, X., Li, S., & An, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411072 · Cited by 10
The impact of POSTN on tumor cell behavior and the tumor microenvironment in lung adenocarcinoma
Sun, D., Lu, J., Tian, H., Li, H., Chen, X., Feng, H., Yang, W., Yu, J., & Chen, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113713 · Cited by 13
Xiao, C., Tan, L., Liu, X., Zhou, M., Chen, P., Wang, Z., & Wang, B. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1538649 · Cited by 10
Nabi‐Afjadi, M., Farzam, F., Soltani, S., Golestani, N., Asl, S. S., Aziziyan, F., Zalpoor, H., Ghasemi, F., Dabirmanesh, B., & Khajeh, K. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03959-9 · Cited by 12
“It promotes cancer stem cell-supporting niche formation and thereby maintains CSCs [79].”
A Heterotypic Tridimensional Model to Study the Interaction of Macrophages and Glioblastoma In Vitro
Gattas, M. J., Estecho, I. G., Huvelle, M. A. L., Errasti, A. E., Silva, E. A. C., & Simian, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105105 · Cited by 12
“However, 30–40% of the cell composition of gliomas is accounted by the presence of macrophages, being 85% of them derived from bone marrow infiltrating monocytes and macrophages [22] and the remaining 15% corresponds to locally resident microglia [23].”
BackgroundRao, C., Jin, J., Lu, J., Wang, C., Wu, Z., Zhu, Z., Tu, M., Su, Z., & Li, Q. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.822735 · Cited by 10
“In addition, M2-like macrophages also significantly promote angiogenesis and induce immunosuppression (37).”
BackgroundIglesia, R. P., Prado, M. B., Alves, R. N., Melo-Escobar, M. I., Fernandes, C. F. D. L., Fortes, A. C. D. S., Souza, M. C. D. S., Boccacino, J. M., Cangiano, G., Soares, S. R., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.907423 · Cited by 11
Guo, L., Yan, T., Guo, W., Niu, J., Wang, W., Ren, T., Huang, Y., Xu, J., & Wang, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.986785 · Cited by 11
Robilliard, L. D., Yu, J. J., Anchan, A., Finlay, G. J., Angel, C. E., & Graham, E. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214164 · Cited by 11
The strange Microenvironment of Glioblastoma
Brisson, L., Geraldo, L. H., Bikfalvi, A., & Mathivet, T. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.03.007 · Cited by 11
Non-targeted effects of radiation therapy for glioblastoma
Lerouge, L., Ruch, A., Pierson, J., Thomas, N., & Barberi‐Heyob, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30813 · Cited by 13
“Consequently, M2-type microglia/macrophages favor tumor progression [27].”
Polysome Profiling of a Human Glioblastoma Reveals Intratumoral Heterogeneity
Lupinacci, F. C. S., Kuasne, H., Roffé, M., Vassalakis, J. A., da Silva, F. F., Santos, T. G., de Andrade, V. P., Sanematsu, P., Martins, V. R., Rogatto, S. R., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092177 · Cited by 10
“Periostin was previously described as involved in GBM progression, resistance to antiangiogenic therapies and immune infiltration [26,27].”
BackgroundTu, J., Fang, Y., Han, D., Tan, X., Xu, Z., Jiang, H., Wang, X., Hong, W., & Wei, W. (2022) · Oncogene · doi:10.1038/s41388-022-02236-7 · Cited by 12
“macrophages by blocking integrin αvβ3 signaling [35].”
Cancer stem cells: Masters of all traits
Leck, L. Y. W., El-Aziz, Y. S. A., McKelvey, K. J., Park, K. C., Sahni, S., Lane, D. J. R., Skoda, J., & Jansson, P. J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167549 · Cited by 12
Yang, Q., Yan, J., & Yang, Q. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70601 · Cited by 12
“136,137 Colorectal cancer cells deliver MFGE8 via exosomes to bridge PS on apoptotic cells with α v β 3 on macrophages.”
Peng, Z., Wang, J., Tong, S., Wu, Y., Yi, D., & Xiang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128151 · Cited by 10
“GSCs also induce the M2 phenotype in macrophages, suppressing an immune response and enabling tumor evasion from immune cell clearance (52).”
BackgroundLIN28B and Let-7 in Diffuse Midline Glioma: A Review
Knowles, T., Huang, T., Qi, J., An, S., Burket, N. J., Cooper, S. H., Nazarian, J., & Saratsis, A. M. (2023) · Cancers · doi:10.3390/cancers15123241 · Cited by 9
Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining
Faried, A., Hermanto, Y., Tjahjono, F. P., Valentino, A., & Arifin, M. Z. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.11.077 · Cited by 10
Tumor Microenvironment — Perivascular and Perinecrotic Niches
Schiffer, D., Mellai, M., Annovazzi, L., Casalone, C., & Cassoni, P. (2015) · InTech eBooks · doi:10.5772/58962 · Cited by 10
Spinal Cord Tumor Microenvironment
Rauschenbach, L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36214-0_8 · Cited by 10
Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis
Aleebrahim‐Dehkordi, E., Deravi, N., Fallahi, M. S., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_66-1 · Cited by 9
Empowering Healthcare with Phage Display Technology
Lyu, B., Zhou, H., Wang, H., Wang, X., Huang, Z., Xu, Y., Hu, Z., & Peng, H. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00218 · Cited by 8
Xu, Z., Fang, X., Wang, S., Mu, J., Gai, Q.-Z., Chen, Y., Sun, Z., & Zhai, J. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.05.006 · Cited by 8
“TAMs promote tumor progression through multiple mechanisms, including enhancing cancer cell proliferation and migration, facilitating immune evasion, and suppressing apoptosis [8].”
Xie, Q., Chen, L., Huang, Y., Yu, Z., Zhu, R., Li, J., Zhao, J., Song, Y., Li, H., & Lu, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08313-5 · Cited by 8
PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis
Wang, Y., Wang, B., Cao, W., & Xu, X. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149665 · Cited by 9
Domrachev, B., Singh, S. S., Li, D., & Rudloff, U. (2021) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2021/1.1194 · Cited by 8
Chen, M., Zhang, Z., Yang, M., & Li, S. (2019) · Child s Nervous System · doi:10.1007/s00381-019-04178-0 · Cited by 8
Raggi, C., Correnti, M., Sica, A., Andersen, J. B., Cardinale, V., Alvaro, D., Chiorino, G., Glaser, S. G., Alpini, G. D., Sozio, F., et al. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)01661-5 · Cited by 11
Yang, W., Warrington, N. M., Taylor, S. J., Carrasco, E., Singleton, K., Wu, N., Lathia, J. D., Berens, M. E., Kim, A. H., Barnholtz‐Sloan, J. S., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/232744 · Cited by 8
“Six of the nine transcripts from this pathway (PLAT (29), CHL1 (30, 31), FERMT1 (32), PCDH8 (33), IGFBP2 (34, 35), POSTN (36)) have previously reported roles in glioma, and three (PLAT, IGFBP2 and POSTN) have been reported to distinguish Proneural from Classical subtype GBM consistent with the high rate of IDH1 mutant…”
ResultTGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth
Marvin, D. L., Dijkstra, J. J., Zulfiqar, R. M., Vermeulen, M., ten Dijke, P., & Ritsma, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108676 · Cited by 8
Metabolic vulnerability of cancer stem cells and their niche
Marrone, L., Romano, S., Malasomma, C., Giacomo, V. D., Cerullo, A., Abate, R., Vecchione, M. A., Fratantonio, D., & Romano, M. F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1375993 · Cited by 7
“TAMs are the leading players in the CSC niche, they physically interact with CSCs and secrete a variety of soluble factors to protect them from environmental damage (Jinushi et al., 2011; Fan et al., 2014; Zhou et al., 2015; Oshimori, 2020).”
BackgroundSingle-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma
Licón-Muñoz, Y., Avalos, V., Subramanian, S., Granger, B., Martinez, F. J., García‐Montaño, L. A., Varela, S., Moore, D., Perkins, E., Kogan, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115149 · Cited by 14
Exosome tropism and various pathways in lung cancer metastasis
Chen, H., Liu, L., Xing, G., Zhang, D., Niumuqie, A., Huang, J., Li, Y., Zhao, G., & Liu, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1517495 · Cited by 12
“In turn, M2-type TAMs enhance tumor cell proliferation and EMT (112) and promote tumor angiogenesis, PMN formation, immune escape, and ultimately tumor growth and metastasis (80, 112, 113).”
Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches
Ribeiro, A., Fote, G., Himstead, A. S., Zheng, M., Elliott, E., Smith, S. M., Lou, J. J., & Yuen, C. (2025) · Biomedicines · doi:10.3390/biomedicines13081963 · Cited by 9
“In turn, TAMs recruit additional macrophages and monocytes, reinforcing the immunosuppressive microenvironment [36–38].”
Tian, G., Song, Y., Zhang, Y., Kan, L., Hou, A., & Han, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07034-9 · Cited by 10
“[22, 30, 107, 110, 111] Extracellular vesicles (EVs) have a crucial impact within the TME and are instrumental in the PMT (Fig.”
Mesenchymal stem cells regulating macrophage polarization
Li, H., Wang, T., Yang, C., Dong, W., Wu, J., Zhang, J., Xu, F., Xie, Z., Liang, L., Zhang, K., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115801 · Cited by 12
Consensus statement on microglial and macrophage functions in gliomas
Zheng, Y., Alzoubi, I., Graeber, M. B., Anand, A., Barazzuol, L., Dorostkar, M. M., Frontzek, K., Golebiewska, A., Hadjipanayis, C. G., Hortobágyi, T., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02999-3 · Cited by 15
Inhibition of Postn Rescues Myogenesis Defects in Myotonic Dystrophy Type 1 Myoblast Model
Shen, X., Liu, Z., Wang, C., Xu, F., Zhang, J., Li, M., Lei, Y., Wang, A., Bi, C., & Zhu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.710112 · Cited by 7
“In glioma, Postn promotes tumor growth, epithelial– mesenchymal transition (EMT), invasion, and resistance to antiangiogenic therapy by recruiting M2 macrophages and activating STAT3 (Zhou et al., 2015; Park et al., 2016).”
BackgroundImmune Profiling of Meningiomas
Wang, J. Z., Nassiri, F., Bi, L., & Zadeh, G. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-29750-2_14 · Cited by 7
Mahanti, K., & Bhattacharyya, S. (2023) · Translational research · doi:10.1016/j.trsl.2023.10.003 · Cited by 7
Xu, H., Chen, F.-X., Li, K., Zhang, Q., Han, N., Li, T., Xu, Y., Chen, Y., & Chen, X. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01595-w · Cited by 6
GBM Immunotherapy: Macrophage Impacts
Loginova, N., Aniskin, D., Timashev, P. S., Ulasov, I. V., & Kharwar, R. K. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2337022 · Cited by 7
“In one such study, periostin produced by glioblastoma stem cells (GSCs) was found to enhance TAM recruitment into human GBM via integrin (Zhou et al., 2015).”
Alqarni, A., Jasim, S. A., Altalbawy, F. M. A., Kaur, H., Kaur, I., Rodriguez‐Benites, C., Deorari, M., Alwaily, E. R., Al‐Ani, A. M., & Redhee, A. H. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23719 · Cited by 9
Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma
Fujimura, T., Furudate, S., KAMBAYAHSI, Y., Kakizaki, A., Yamamoto, Y., Okuhira, H., Fujimoto, N., & Aiba, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11571 · Cited by 7
Heterogeneous Periostin Expression in Different Histological Variants of Papillary Thyroid Carcinoma
Giuşcă, S. E., Amălinei, C., Lozneanu, L., Apostol, D. C., Andriescu, E. C., Scripcariu, A., Balan, R. A., Avădănei, E. R., & Căruntu, I.-D. (2017) · BioMed Research International · doi:10.1155/2017/8701386 · Cited by 7
Goldshmit, Y., Perelroizen, R., Yakovchuk, A., Banyas, E., Mayo, L., David, S., Benbenishty, A., Blinder, P., Shalom, M., & Ruban, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-94183-8 · Cited by 7
Periostin: A matricellular protein with a multifaceted role in tumorigenesis (Review)
Xian, Y., & Wang, L. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5670 · Cited by 9
“This POSTN‑mediated crosstalk sustains gSc‑TAM clustering in perivascular regions, fostering therapy resistance and recur‑ rence (101,151,152).”
Abdi, H., Arabi, L., Montazer, M., Askarizadeh, A., Zamani, P., Hosseinzadeh, H., Jaafari, M. R., & Mosaffa, F. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121992 · Cited by 6
Xu, H., Chen, X., Zhu, S.-Y., Xue, F., & Zhang, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117675 · Cited by 6
Yang, Y., Luo, X., Wang, Y., Xu, A., Peng, L., Zhang, X., Wang, Z., Ying, Y., & Li, K. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117074 · Cited by 7
Liao, S. (2024) · American Journal of Cancer Research · doi:10.62347/bnpo2363 · Cited by 6
The integrin adhesome and control of anti-tumour immunity
Webb, E. R., Black, A., Barth, N. D., Symeonides, S. N., & Brunton, V. G. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240386 · Cited by 7
Genome-wide translation patterns in gliomas: An integrative view
Hajj, G. N. M., Nunes, P. B. C., & Roffé, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109883 · Cited by 6
Wang, Q., & Wang, Z. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23541 · Cited by 8
Luan, Y., Zhang, H., Liu, Y., Xue, J., Wang, K., Ma, B., Ma, K., Lü, H., Chen, X., Liu, Y., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31178 · Cited by 8
“…plays a crucial role in regulating tumor progression and tumorigenesis by remodeling various tumor micro-environments, such as CSCs niche, perivascular niche, and immuno-suppressive microenvironment (Ghajar et al., 2013; González ‐ González & Alonso, 2018; Masuoka et al., 2012; Zhou et al., 2015).”
BackgroundKalluri, H. S. G., Kuo, J. S., & Dempsey, R. J. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.026 · Cited by 6
“…of cellular growth is a major characteristic feature of tumor cells due to either abnormal growth factor secretion (Venkatesh et al., 2015; Zhou et al., 2015) or mutation in growth factor receptor (Nishikawa et al., 1994) resulting in constitutive activation of the receptors leading to…”
BackgroundStemness features in liver cancer
Correnti, M., Booijink, R. S., Maira, G. D., Raggi, C., & Marra, F. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.96 · Cited by 7
“In addition, recent studies also suggest that similar to normal stem cells, CSCs seem to reside in specialized microenvironment (“CSC-niche”)([46,50,70,172]), whose signals can support self-renewal and drug-resistance features and, thereby, may influence the plasticity of CSCs([173-177]).”
BackgroundSarkar, S., Li, Y., Mirzaei, R., Rawji, K. S., Poon, C. C., Wang, J., Kumar, M., Bose, P., & Yong, V. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00272 · Cited by 6
“For example, glioma cells have been shown to secrete periostin, which selectively recruits macrophages with an immunosuppressive profile (19).”
BackgroundDNA Damage Repair in Brain Tumor Immunotherapy
Zhao, S., Xu, B., Ma, W., Chen, H., Jiang, C., Cai, J., & Meng, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.829268 · Cited by 6
“From this point of view, GSCs is a key biomarker for glioma immunotherapy, and some oncolytic viruses (OVs) targeting the effects of GSCs have been deeply studied.”
BackgroundInfluentialLow periostin expression predicts poor survival in intestinal type gastric cancer patients
Zhang, T., Han, Z., Chandoo, A., Huang, X., Sun, X., Ye, L., Hu, C., Xue, X., Huang, Y., Shen, X., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s175596 · Cited by 7
The Effect of Glioblastoma on Pericytes
Molina, M. L., & Valdor, R. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00016-7 · Cited by 7
Periostin—a new potential target for the treatment of glioblastoma
Errico, A. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.15 · Cited by 6
García‐Carrizo, F., Gohlke, S., Lenihan-Geels, G. N., Jank, A., Leer, M., Soultoukis, G. A., Oveisi, M., Herpich, C., Garrido, C. A., Kotsaris, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.27.568776 · Cited by 7
“Treatment of BMDM and THP-1 macrophages with Cilengitide, an inhibitor of ITGαv/β3 and ITGαv/β5 heterodimers 56,57 , resulted in a significant reduction of rPOSTN-induced expression of anti-inflammatory surface protein CD206 and similar effects on Mrc1 , which encodes for CD206, and Cd163 mRNA…”
BackgroundGajón, J. A., Juárez-Flores, Á., Mendoza-Roldan, F., Hernández-Aceves, J. A., Muñoz-Cruz, S., Pérez‐Torres, A., Fuentes‐Pananá, E. M., & Bonifaz, L. C. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2595360 · Cited by 5
Li, J., Moqbel, A. Q., Wang, Y., Zhao, E., Ghani, M. U., & Liang, P. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117724 · Cited by 7
Neural stem cells and glioblastoma stem cells: Redefining concepts
Arce, V. M., Gonzalez-Rendo, L., Porres-Ventin, L., González-Álvarez, V., Caamaño-Teixeira, S., Almengló, C., Señarís, R. M., & Costoya, J. A. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105187 · Cited by 5
Correlation Between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma
Wasik, A., Podhorska‐Okołów, M., Dzięgiel, P., Piotrowska, A., Kulus, M., Kmiecik, A. M., & Ratajczak‐Wielgomas, K. (2024) · Cells · doi:10.3390/cells13171406 · Cited by 5
“Similarly, Zhou et al. [94] showed that the inhibition of POSTN expression in glioma stem cells inhibited tumor growth and prolonged murine survival.”
Role of the Extracellular Matrix in Tumor Stroma: Barrier or Support?
Zeltz, C., Navab, R., Kusche‐Gullberg, M., Tsao, M., & Gullberg, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_4 · Cited by 6
Kanazawa, T., Ohara, K., Kitamura, Y., Nakaya, M., Yoshida, K., & Sasaki, H. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03855-y · Cited by 5
Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma
Zhang, X., Guo, Q., Zhao, Z., Cheng, P., Wu, A., & Liu, H. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145557 · Cited by 7
Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma
Wei, J., Liu, Y., & Zhao, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719973 · Cited by 6
“IHC staining of paraffin-embedded sections was carried out manually as reported previously (15).”
MethodAdipose Tissue-Derived Stem Cells in Regenerative Medicine and Impact on Cancer
Thiagarajan, P. S., & Reizes, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803892-5.00016-4 · Cited by 7
Kalluri, H. S. G., Kuo, J. S., & Dempsey, R. J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.001 · Cited by 5
“, 2012) either due to autocrine secretion of growth factors (Zhou et al., 2015) or a mutation in growth factor receptors (Nishikawa et al.”
BackgroundUpregulation of periostin in MOG-induced experimental autoimmune encephalomyelitis in mice
Choi, Y., Kim, J., Ahn, M., & Shin, T. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134558 · Cited by 5
Morrone, M. D. S., Somensi, N., Franz, L., Ramos, V. D. M., Gasparotto, J., da Rosa, H. T., Sartori, M., Figueiró, F., Gelain, D. P., Zanotto‐Filho, A., et al. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03605-9 · Cited by 7
Pang, Q. Y., Novera, W., Koh, L., Chong, Y. K., Lim, S. W., Sim, N. L., Rizzetto, S., Liu, J., Lin, X., Ang, S. Y. L., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf145 · Cited by 4
“58 In vitro, exposure to a conditioned medium from THP-1-derived macrophages ( Supplementary Figure S10B and C ) strongly induced mesenchymal marker expression, CD44, and suppressed that of proneural Olig2 in our proneural cells.”
The lncrnas: innovative multifunctional players of drug resistance in colorectal cancer
Maghsoudi, H., Rasoulzadeh, M., Abbastabar, M., Fazilat, A., Sheikhnia, F., Azizzadeh, B., Valilo, M., & Majidinia, M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03951-3 · Cited by 5
“Tumor-associated macrophages also support breast and brain CSCs, further emphasizing the significance of the microenvironment in determining CSC characteristics [111, 112].”
Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions
Wang, M., Wang, X., Jin, X., Zhou, J., Zhang, Y., Yang, Y., Liu, Y., & Zhang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175118 · Cited by 4
Cyclooxygenase-2 as a potential therapeutic target in the treatment of chemoresistant glioblastomas
Skossyrskiy, V. S., Kurdina, N. A., Kuzovkova, V. S., Boot, M. S., Zelenchenkova, P. I., Popova, E. O., Sevyan, N. V., Mitrofanov, A. A., Прозоренко, Е. В., Sekacheva, M. I., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-03000-z · Cited by 4
“Within GBM, TAMs predominantly adopt an immunosuppressive, M2-like phenotype [46, 47].”
Wu, J., Liu, X., Huang, S., & Liu, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072933 · Cited by 6
“In turn, these cytokines recruit myeloid-derived suppressor cells (MDSCs) and facilitate the development of a tumor-promoting microenvironment [22].”
Chopra, A. S., Liu, X., & Liu, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803892-5.00013-9 · Cited by 5
Yang, Y., Wu, J., Cheng, C., Bao, D., Dong, Y., Li, D., Niu, W., Zhou, C.-X., & Niu, C. (2018) · Europe PMC (PubMed Central) · Cited by 5
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.